Dr Nick Zdenkowski - Medical Oncologist
BMed, FRACP, PhD
Dr Nick Zdenkowski is a Medical Oncologist who is trained in general oncology. He sees patients with a range of different types of cancer, and has a special interest in the care of patients with breast and gastro-intestinal cancer. He values shared decision-making in diagnostic and treatment decisions, to ensure that the preferences of patients and their support people are at the centre of their care. He offers patient-centred, evidence-based treatment which gives the best possible outcome for each individual.
Dr Nick offers the latest in medical oncology treatments for breast cancer, including chemotherapy, targeted therapies, and hormone-blocking therapies. Chemotherapy and targeted therapies are delivered under his supervision by a team of specialised oncology nurses in a modern, comfortable day treatment centre at Maitland Private Hospital. He also sees patients at The Breast and Endocrine Centre in Gateshead, and treats patients at the Lake Macquarie Private Hospital Day Oncology Unit.
Highly Qualified Medical Oncologist
Dr Nick was awarded his PhD in 2018 from the University of Sydney, which focussed on shared decision-making in cancer care. He completed his Bachelor of Medicine undergraduate training at the University of Newcastle in 2005 before proceeding to Physician training at Royal North Shore Hospital in Sydney, and Medical oncology training in Newcastle culminating in Fellowship of the Royal Australasian College of Physicians in 2012. During this time, he also completed a Graduate Diploma in Clinical Epidemiology at the University of Newcastle and a Clinical Diploma of Palliative Care with the College of Physicians.
Passionate about Oncology
In the rapidly changing world of oncology, keeping up to date with the best medical evidence is vital. Dr Nick Zdenkowski regularly attends national and international conferences to offer the best possible treatments and advice. He also has a strong research interest, having published more than 33 peer-reviewed manuscripts since 2012, and presented his research at national and international scientific meetings. He sits on the Scientific Advisory Committee of Breast Cancer Trials, a national collaborative clinical trials group, and works with that Group as a Medical Advisor. He also sits on a number of trial and research Steering Committees. He collaborates with researchers in Newcastle, Australia and internationally to improve the lives of all patients with breast cancer.
Committed to more testing
“The idea behind screening is to identify cancers at an earlier stage so they can be treated with better cure rates and a better prognosis.”
Dr Nick Zdenkowski